Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Histamine h3 receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS.
[Corticotherapy and suicidal behavior: A case report].
The Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.
Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.
Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration.
Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis.
Multiple sclerosis: IL-12p40-an early biomarker for multiple sclerosis?
Bilateral optic neuritis associated with scrub typhus.
Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability.
Chronic Inflammatory Pure Sensory Polyradiculoneuropathy: A Rare CIDP Variant With Unusual Electrophysiology.
Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.
Meningoencephalitis-like onset of post-infectious AQP4-IgG-positive optic neuritis complicated by GM1-IgG-positive acute polyneuropathy.
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Small molecules with anti-inflammatory properties in clinical development.
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
Multiple sclerosis: Worrying data on excess mortality and comorbidity in MS.
Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman.
Progressive Multifocal Leukoencephalopathy.

Pages